Discovery of pulmonary fibrosis inhibitor targeting TGF-I3 RI in Polygonum cuspidatum by high resolution mass spectrometry with in silico strategy

Pulmonary fibrosis (PF) is an irreversible lung disease that is characterized by excessive scar tissue with a poor median survival rate of 2-3 years. The inhibition of transforming growth factor-I3 receptor type-I (TGF-I3 RI) by an appropriate drug may provide a promising strategy for the treatment of this disease. Polygonum cuspidatum (PC) is a well-known traditional Chinese herbal medicine which has an anti-PF effect. Accordingly, a combination of high resolution mass spectrometry with an in silico strategy was developed as a new method to search for potential chemical ingredients of PC that target the TGF-I3 RI. Based on this strategy, a total of 24 ingredients were identified. Then, absorption, distribution, meta- bolism, and excretion (ADME)-related properties were subsequently predicted to exclude compounds with potentially undesirable pharmacokinetics behaviour. Molecular docking studies on TGF-I3 RI were adopted to discover new PF inhibitors. Eventually, a compound that exists in PC known as resveratrol was proven to have excellent biological activity on TGF-I3 RI, with an IC50 of 2.211 mu M in vitro. Furthermore, the complex formed through molecular docking was tested via molecular dynamics simulations, which revealed that resveratrol had strong interactions with residues of TGF-I3 RI. This study revealed that resveratrol has significant potential as a treatment for PF due to its ability to target TGF-I3 RI. In addition, this research demonstrated the exploration of natural products with excellent biological activities toward specific targets via high resolution mass spectrometry in combination with in silico technology is a promising strategy for the discovery of novel drugs.(c) 2022 The Authors. Published by Elsevier B.V. on behalf of Xi'an Jiaotong University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Automated summary

This study developed a new method using high resolution mass spectrometry and in silico strategy to search for potential chemical ingredients in Polygonum cuspidatum (PC) that target the TGF-I3 RI. Resveratrol, a compound found in PC, was identified to have excellent biological activity on TGF-I3 RI and potential as a treatment for PF.